Veralox Therapeutics raises $5.4m in seed funding co-led by JDRF T1D Fund and Sanofi Ventures

This article was originally published here

The funding was led by the JDRF T1D Fund, Sanofi Ventures, and the VTC Innovation and VTC Seed Fund, with participation from the Maryland Momentum Fund, the University

The post Veralox Therapeutics raises $5.4m in seed funding co-led by JDRF T1D Fund and Sanofi Ventures appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply